Related references
Note: Only part of the references are listed.Gastric Cancer, Version 2.2022
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer
Arghya Ganguly et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
Zimin Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis
Kristian Egebjerg et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Hepatobiliary Cancers, Version 2.2021
Al B. Benson III et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Colonic Adenocarcinomas Harboring NTRK Fusion Genes A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature
Jerzy Lasota et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Inflammation-induced DNA damage, mutations and cancer
Jennifer Kay et al.
DNA REPAIR (2019)
Esophageal and Esophagogastric Junction Cancers, Version 2.2019
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
A model for RAS mutation patterns in cancers: finding the sweet spot
Siqi Li et al.
NATURE REVIEWS CANCER (2018)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Current Role of Genetics in Hematologic Malignancies
Gaurav Prakash et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Current Role of Genetics in Hematologic Malignancies
Gaurav Prakash et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Molecular Pathology: A Requirement for Precision Medicine in Cancer
Manfred Dietel
ONCOLOGY RESEARCH AND TREATMENT (2016)
Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival
Aatur D. Singhi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
T. Golan et al.
BRITISH JOURNAL OF CANCER (2014)
Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
Ludmil B. Alexandrov et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
Yasuhito Arai et al.
HEPATOLOGY (2014)
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas
Alyssa M. Krasinskas et al.
MODERN PATHOLOGY (2014)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing
Winnie S. Liang et al.
PLOS ONE (2012)
An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
Maeve A. Lowery et al.
ONCOLOGIST (2011)
Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression
Li-Hui Wang et al.
CLINICAL CANCER RESEARCH (2007)
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-β receptor defects
E Montgomery et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Gemcitabine: Progress in the treatment of pancreatic cancer
V Heinemann
ONCOLOGY (2001)
Share Paper
